PatternsRadar
Sign in

MANIPALHOSManipal Health Enterprises Limited

NSE
702.20INR+5.75 (+0.83%)Close · 20 Nov 2026
13 Nov 2026Last results
HealthcareSector
Healthcare ServicesIndustry
₹92,366 CrMarket cap
—P/E (TTM)
58.8%Delivery

Filings & corporate actions

2 results filed
CSV
2026
  • 13 NovresultsResults · Q2 FY27 · consolidated and standalone+1.4%NSE
  • 19 OctshareholdingShareholding · 30 Sept 2026-1.9%NSE
  • 20 AugresultsResults · Q1 FY27 · consolidated and standalone-1.2%NSE
  • 5 AugshareholdingShareholding · 4 Aug 2026NSE

Reaction to results · all yearsrose on day 0 in 1 of 2 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2713 Nov 2026+1.4%——2.7×
Q1 FY2720 Aug 2026-1.2%+6.5%+3.1%—
Average+0.1%+6.5%+3.1%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY—
Profit YoY—
Interest cost YoY—
Revenue QoQ+10.0%
Profit QoQ+16.5%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

Open690.00
Day range686.10 – 716.60
52-week range—
From 52w high—
RSI (14)59.6
ATR (14)26.11
Volume11.62L
Avg volume (20D)12.33L
Rel volume0.94×
Volatility (1Y)36.4%
Turnover₹82.3Cr
Traded value (NSE)₹82.3Cr
VWAP708.22
SMA 50 / 200683.78 / —
Price band20%

Delivery percentage

Latest · 20 Nov 202658.8%
20-day avg62.2%
1-year avg52.9%
Percentile (own history)72nd
Range32.5–84.7%
Sessions75

Over the last 20 sessions MANIPALHOS settled 62.2% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 52.9%, so recent sessions are running 9.3 points higher than usual.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders1.72L · -49.1% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buynever

Performance returns

1D1W1M3M6M1Y
Price+0.83%+3.05%+12.28%-3.06%——

Valuation

Market cap₹92,366 Cr
Market cap (NSE)₹92,366 Cr
Free-float cap₹25,789 Cr
P/E (TTM)—
EPS (TTM)—
P/B5.5
Net margin (TTM)—
Other income / PBT—
ROE—
Debt / equity0.34
Shares outstanding131.54Cr
Listed5 Aug 2026

Ownership

Promoter72.08%
Promoter Δ QoQ0.00 pp
Public27.92%
FII3.50%
DII7.18%
Pledged20.78%

Quarterly results · consolidated

Q1 FY27Q2 FY27
Revenue (₹ Cr)3,090.63,399.4
YoY chg——
Net profit (₹ Cr)243.4285.0
YoY chg——
Net margin7.9%8.4%
EPS1.962.12

Shareholding over time

By quarter

30 Sept 2026 · promoter 72.08% · public 27.92%
4 Aug 2026: promoter 72.08%30 Sept 2026: promoter 72.08%
2026-082026-09
  • Promoter
  • Public and others
Promoter
72.08%
Public
27.92%
Promoter change
0.00 pp
Filed
19 Oct 2026
FII
3.50%
DII
7.18%
Promoter pledged
20.78%

Who the public is

Mutual funds
4.63%

+1.10 pp QoQ

Insurance
0.68%

+0.05 pp QoQ

FPI
3.51%

-0.15 pp QoQ

Retail ≤ ₹2L
1.04%

-1.14 pp QoQ

HNI > ₹2L
0.02%

-0.13 pp QoQ

NRI
0.02%

0.00 pp QoQ

Bodies corporate
0.14%

-0.13 pp QoQ

Shareholders
1,72,129

-49.1% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
KANGTO INVESTMENTS PTE. LTDPromoter · Foreign23.73%
MANIPAL GLOBAL HEALTH SERVICESPromoter · Foreign17.65%
IMPERIUS HEALTHCARE INVESTMENTS PTE. LIMITEDPromoter · Foreign15.11%
TPG SG MAGAZINE PTE. LTD.Corporate9.10%
KABRU INVESTMENTS PTE. LTDPromoter · Foreign5.19%
MANIPAL EDUCATION AND MEDICAL GROUP INDIA PRIVATE LIMITEDPromoter · Corporate4.30%
CYPRESS HOLDINGSPromoter · Foreign3.74%
SEVENTY SECOND INVESTMENT COMPANY LLC - FDICorporate3.23%
MEMG INTERNATIONAL INDIA PRIVATE LIMITEDPromoter · Corporate1.81%
AMMAR SDN BHDCorporate1.65%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Bulk & block deals · 21 Oct 2026

CSV
2 of 2 deals
By year
DateDealClientQuantityPriceValue
21 Oct 2026Buy · blockPI OPPORTUNITIES AIF V LLP18.98L630.00₹119.6Cr
21 Oct 2026Sell · blockPRAZIM TRADING AND INVESTMENT COMPANY PRIVATE LIMITED18.98L630.00₹119.6Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

20 Nov 2026
  • P/E > 50 (4 quarters) · since 16 Nov 2026 — P/E above 50 on the last four quarters’ earnings.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
 Q1 FY27Q2 FY27
Revenue from operations3,090.63,399.4
Other income74.699.7
Total income3,165.23,499.1
Total expenses2,834.53,032.3
└ Finance costs293.3300.1
└ Depreciation187.3204.9
Profit before tax315.2371.6
Tax expense71.886.6
Net profit243.4285.0
EPS1.962.14
Net margin7.88%8.38%
PBT margin10.20%10.93%
Tax rate22.76%23.30%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 13 Nov 2026.

2 quarters on file; a year-on-year comparison needs five.

Balance sheet & cash flow · half-yearly

₹ crore, as filed

Balance sheet

 H1 FY27
Total assets28,969.5
Current assets7,004.1
└ Cash & equivalents559.3
└ Other bank balances2,038.3
└ Current investments2,637.8
└ Trade receivables1,245.8
└ Inventories206.7
Total equity17,106.6
└ Attributable to owners16,706.7
└ Non-controlling interest399.9
└ Share capital263.1
Borrowings5,748.1
└ Current366.4
└ Non-current5,381.8
Trade payables1,749.4
Current liabilities3,672.8
Total liabilities11,863.0
Net debt512.8
Debt / equity0.34
Current ratio1.91

Cash flow, year to date

 H1 FY27
Operating cash flow1,191.5
└ Capex(1,295.1)
Free cash flow(103.6)
Investing cash flow(3,370.7)
Financing cash flow2,439.2
└ Dividends paid0.0
└ Buybacks0.0
Net change in cash260.0

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

MANIPALHOS at a glance

  • MANIPALHOS closed at ₹702.2 on 20 Nov 2026, +0.83% on the day.
  • Delivery was 58.8% of traded quantity on 20 Nov 2026, the 72nd percentile of its own 75 sessions with a reading (20-session average 62.2%, 1-year average 52.9%).
  • Market capitalisation is ₹92,366 crore, with no positive trailing earnings for a P/E.
  • Q2 FY27 results (consolidated, filed 13 Nov 2026): revenue ₹3,399 crore, net profit ₹285 crore; the price moved +1.4% on the first session after.
  • Promoters held 72.08% at 30 Sept 2026, unchanged on the previous filing, with 20.78% of promoter shares pledged.

About

Macro sectorHealthcare
Basic industryHospital
ISININE459N01021
SeriesEQ
Listed5 Aug 2026
IPO price590.00 · band Rs.560 to Rs.590
IPO listing5 Aug 2026
NSE market cap · 17 Nov 2026₹92,333 Cr
Free-float market cap (NSE)₹5,974 Cr
Shares outstanding (NSE)131.54Cr
History from5 Aug 2026
Sessions75
Turnover rank#330

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.